RAC 2.01% $1.52 race oncology ltd

Buyout or Partnership- Which is better for Shareholders, page-4

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29635
    Juno - USD $1B partnership in June 2015

    https://www.fiercebiotech.com/partn...al-to-buy-into-juno-s-pipeline-of-car-t-drugs

    UPDATED: Celgene pays $1B in landmark deal to buy into Juno's pipeline of CAR-T drugs


    Jun 29, 2015 4:26pm
    Celgene ($CELG) is paying about $1 billion to move to the front of the hectic race to build new CAR-T cancer therapies. The Big Biotech is shelling out $150 million upfront and paying $93 a share--a huge premium--to snap up 9.1 million shares of Juno Therapeutics ($JUNO), inking a global collaboration to develop and commercialize new immuno-oncology therapies.

    to a USD $9B buyout 2.5 years later

    https://www.fiercebiotech.com/biotech/celgene-confirms-9bn-juno-buyout-sees-3bn-sales-for-jcar017
    Celgene confirms $9B Juno buyout, sees $3B sales for JCAR017


    Jan 22, 2018 11:07am

    Celgene has agreed to buy CAR-T specialist Juno Therapeutics for around $9 billion in a deal that instantly makes it a big cheese in this emerging therapeutic category.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.52
Change
0.030(2.01%)
Mkt cap ! $254.2M
Open High Low Value Volume
$1.51 $1.53 $1.48 $141.7K 94.55K

Buyers (Bids)

No. Vol. Price($)
2 427 $1.50
 

Sellers (Offers)

Price($) Vol. No.
$1.52 2999 2
View Market Depth
Last trade - 16.10pm 21/05/2024 (20 minute delay) ?
Last
$1.51
  Change
0.030 ( 0.85 %)
Open High Low Volume
$1.52 $1.53 $1.48 13236
Last updated 15.53pm 21/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.